ARCHIVES

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

This article is from The Cancer Letter archive.

Vol. 16 No. 31 | August 3, 1990

Download PDF Visit The Full Archive

Related Articles

Senate Passes Extension Ac; Kennedy Plans Saccharin Hearing

May 13, 1977

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

“Great Charlie Moertel Shootout: In Tucson Draws Laughs, Criticism

April 17, 1981

Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.

October 31, 2003

AACI To Become More Aggressive In Developing National Issues; Planning To Start on Collaborate Diagnosis Network

July 15, 1983

NIDDK Funds Trial On treatment Of Chronic Hepatitis C

August 13, 1999